Citigroup
OPTN

Citigroup’s OptiNose OPTN Stock Holding History

Citigroup’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,772
Closed -$108K – 5916
2024
Q3 		$108K Buy
10,772
+8,620
+401% +$126K ﹤0.01% 4730
2024
Q2 		$33.6K Buy
2,152
+1,474
+217% +$24.7K ﹤0.01% 4797
2024
Q1 		$14.8K Sell
678
-16
-2% -$355 ﹤0.01% 5116
2023
Q4 		$13.4K Buy
694
+605
+680% +$11K ﹤0.01% 5117
2023
Q3 		$1.64K Sell
89
-2,945
-97% -$53K ﹤0.01% 5015
2023
Q2 		$56K Sell
3,034
-7,152
-70% -$169K ﹤0.01% 4582
2023
Q1 		$295K Sell
10,186
-570
-5% -$15.2K ﹤0.01% 3499
2022
Q4 		$298K Buy
10,756
+9,899
+1,155% +$376K ﹤0.01% 3511
2022
Q3 		$47K Buy
857
+777
+971% +$42.7K ﹤0.01% 4413
2022
Q2 		$4K Sell
80
-35
-30% -$1.29K ﹤0.01% 5700
2022
Q1 		$4K Sell
115
-47
-29% -$1.68K ﹤0.01% 5901
2021
Q4 		$4K Buy
+162
New +$5.42K ﹤0.01% 5683
2021
Q3 		– Hold
0
– – – 6149
2021
Q2 		– Sell
-154
Closed -$7.86K – 6324
2021
Q1 		$9K Sell
154
-302
-66% -$18.4K ﹤0.01% 5706
2020
Q4 		$28K Buy
456
+140
+44% +$8.58K ﹤0.01% 6442
2020
Q3 		$18K Sell
316
-149
-32% -$11K ﹤0.01% 6276
2020
Q2 		$52K Sell
465
-181
-28% -$12.9K ﹤0.01% 5997
2020
Q1 		$43K Buy
646
+71
+12% +$7.15K ﹤0.01% 6111
2019
Q4 		$80K Buy
575
+389
+209% +$50.5K ﹤0.01% 5954
2019
Q3 		$20K Sell
186
-342
-65% -$34.1K ﹤0.01% 6739
2019
Q2 		$56K Buy
528
+139
+36% +$18.3K ﹤0.01% 6364
2019
Q1 		$60K Buy
389
+106
+37% +$12.3K ﹤0.01% 6189
2018
Q4 		$26K Sell
283
-70
-20% -$10K ﹤0.01% 6741
2018
Q3 		$66K Buy
353
+199
+129% +$56.7K ﹤0.01% 6278
2018
Q2 		$65K Buy
154
+106
+221% +$35.7K ﹤0.01% 6082
2018
Q1 		$14K Buy
48
+7
+17% +$1.94K ﹤0.01% 6916
2017
Q4 		$12K Buy
+41
New +$11.5K ﹤0.01% 6962

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Citigroup's OPTN Position: Q4 2024 in Review

Citigroup sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 10,772 shares — an estimated $108K sold.

Citigroup first reported a position in OPTN in Q4 2017 and held it in 26 quarters. The position peaked at $298K in Q4 2022. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Citigroup reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Citigroup sold 10,772 OptiNose shares in Q4 2024, an estimated $108K.
  • Citigroup first reported a position in OptiNose in Q4 2017 and held it in 26 quarters.
  • Citigroup's OptiNose position peaked at $298K in Q4 2022.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.